Robin L. Washington

ROBIN L. WASHINGTON is currently executive vice president and chief financial officer of Gilead Sciences, Inc. Gilead is a thirty billion dollar, research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines to improve the care of patients with life-threatening diseases. Washington is currently a member of the board of directors of Honeywell International and Salesforce.com. She is also a member of the board of visitors, Graziadio School of Business and Management, Pepperdine University; the Presidents Council & Ross Business School advisory board, University of Michigan; and the UCSF Benioff Children’s Hospital Oakland board of directors. Washington is a certified public accountant and earned a BA in business administration from the University of Michigan and an MBA from Pepperdine University. She is also a member of The Council on Foreign Relations and Executive Leadership Council. She has been recognized for her work on numerous occasions, including being awarded the Bay Area CFO of the Year Lifetime Achievement Award in 2017. In 2016, she was recognized as the #1 CFO in Biotechnology by Institutional Investor Magazine and in 2014, she was recognized by The Wall Street Journal as one of the Top 10 Performing CFOs (#6) in the S&P 500. In 2011, Washington received the Graziadio Distinguished Alumnus Award from Pepperdine University. She has also been honored as one of Silicon Valley’s and San Francisco Business Times Women of Influence and Black Enterprise’s 75 Most Powerful Women. @gileadsciences

Subscribe to e-News